Expert Meeting on Disease Management Outcomes Measurement, 71412 [07-6057]
Download as PDF
71412
Federal Register / Vol. 72, No. 241 / Monday, December 17, 2007 / Notices
percent of the voting shares of Bradford
Bancshares, Inc., and thereby indirectly
acquire voting shares of The Bank of
Bradford, both of Bradford, Tennessee.
2. First Banks, Inc., St. Louis,
Missouri; to acquire an additional 1.21
percent, for a total of 24.99 percent, of
the voting shares of Community West
Bancshares, and thereby indirectly
acquire additional voting shares of
Community West Bank, National
Association, both of Goleta, California.
C. Federal Reserve Bank of Kansas
City (Todd Offenbacker, Assistant Vice
President) 925 Grand Avenue, Kansas
City, Missouri 64198–0001:
1. Central Financial Corporation,
Hutchinson, Kansas; to retain 6.04
percent of the voting shares of Valley
Capital Bank, N.A., Mesa, Arizona.
Board of Governors of the Federal Reserve
System, December 12, 2007.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc.E7–24314 Filed 12–14–07; 8:45 am]
BILLING CODE 6210–01–S
GENERAL SERVICES
ADMINISTRATION
[PBS–N02]
Notice of Availability of the Draft
Environmental Assessment and
Wetland Involvement for the
Transformation of Facilities and
Infrastructure for the Non-Nuclear
Production Activities Conducted at the
National Nuclear Security
Administration’s Kansas City Plant at
Kansas City, MO
ebenthall on PROD1PC69 with NOTICES
SUMMARY: GSA published a notice in the
Federal Register at 72 FR 69690 on
Monday, December 10, 2007,
concerning the National Nuclear
Security Administration’s Kansas City
Plant at Kansas City, MO. The document
contained an incorrect state
abbreviation and date format.
DATES: December 17, 2007.
FOR FURTHER INFORMATION CONTACT: Ms.
Diedra Wingate at (202) 501–4755, GSA,
Regulatory Secretariat.
Corrections
In the notice document FR Doc. E7–
23843 on page 69690 make the
following corrections:
In the first column, the last line of the
notice title ‘‘Kansas City, MI’’ should
read ‘‘Kansas City, MO’’. In the second
column, under the heading DATES, in the
third line, ‘‘Monday, January 14th’’,
15:28 Dec 14, 2007
Diedra Wingate,
Regulatory Secretariat.
[FR Doc. E7–24354 Filed 12–14–07; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Expert Meeting on Disease
Management Outcomes Measurement
Department of Health and
Human Services, Office of the Assistant
Secretary for Planning and Evaluation.
ACTION: Notice of meeting.
AGENCY:
SUMMARY: This notice announces the
date and location of the Department of
Health and Human Services, Office of
the Assistant Secretary for Planning and
Evaluation (HHS/ASPE) Expert Meeting
on Disease Management Outcomes
Measurement. The objective of the
meeting is to convene a panel of experts
from government, academia, and private
industry to discuss measurement of the
impact of disease management on health
outcomes and costs of care, with a focus
on potential for public sector programs.
DATES: Wednesday, January 16, 2008,
from 9 a.m. to 5 p.m. Eastern Time.
ADDRESSES: The Expert Meeting will be
held at 1200 South Hayes Street, Room
4204, Arlington, VA 22202–5050.
Telephone: (703) 413–1100. Registration
procedures are described in the
SUPPLEMENTARY INFORMATION section
below.
FOR FURTHER INFORMATION CONTACT:
General Services
Administration (GSA).
ACTION: Correction.
AGENCIES:
VerDate Aug<31>2005
should read ‘‘Monday, January 14,
2008’’.
Jkt 214001
Adelle Simmons, Office of the Assistant
Secretary for Planning and Evaluation,
200 Independence Avenue, SW.,
Washington, DC 20201. Telephone:
(202) 690–5924.
SUPPLEMENTARY INFORMATION:
I. Background
In the face of increasing health care
costs, evidence of the need for systemwide health care quality improvement,
and an aging population, disease
management seems an intuitively
appealing way to improve the
coordination and quality of care, and
ultimately improve health outcomes. In
broad terms, disease management refers
to a system of coordinated health care
interventions and communications to
help patients address chronic health
conditions. Commercial health plans
and large employers are embracing this
strategy, and public purchasers of health
care services including the Centers for
Medicare and Medicaid Services (CMS)
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
have implemented demonstration
programs to evaluate disease
management for certain conditions.
Questions about the effectiveness of
disease management remain, in part,
because the evaluation methods of
vendors of large, population-based
programs often lack scientific validity.
Conversely, vendors often argue that
scientifically credible approaches, like a
randomized controlled experiment that
the Medicare Health Support pilot uses,
are not feasible for routine operation.
Thus, the lack of universally accepted
yet feasible evaluation methods are a
major obstacle to adopting and
improving disease management, because
potential purchasers of such programs
find it hard to identify the best program
design and to monitor its success. A
primary goal of this meeting is to
consider the variety of disease
management programs and identify
strategies to improve the assessment of
their impact on individuals with
multiple chronic conditions.
II. Registration
The meeting is open to the public,
and pre-registration is encouraged.
Seating capacity is limited, so
registration will be accepted on a firstcome, first-served basis. Registration can
be completed by sending an e-mail
message to Ms. Emily Taylor of the
RAND Corporation at etaylor@rand.org
(The RAND Corporation is the
Contractor to HHS/ASPE to provide
logistical support for the Expert
Meeting.) To register by telephone,
contact Ms. Taylor at (703) 413–1100
ext. 5793.
The following information must be
provided when registering: Name,
Company/Organization, and address. A
RAND Corporation staff member will
confirm registrations by mail, e-mail, or
fax.
Note: In the event that the meeting must be
canceled due to inclement weather, the
meeting will be held at a later date, and
registrants will be notified by RAND.
III. Special Accommodations
Individuals who are hearing- or
visually-impaired and have special
requirements or a condition that
requires special assistance must request
accommodation when registering for the
meeting in order to ensure that
accommodations will be made.
Dated: December 12, 2007.
Mary M. McGeein,
Principal Deputy Assistant Secretary for
Planning and Evaluation, Department of
Health and Human Services.
[FR Doc. 07–6057 Filed 12–14–07; 8:45 am]
BILLING CODE 4150–24–M
E:\FR\FM\17DEN1.SGM
17DEN1
Agencies
[Federal Register Volume 72, Number 241 (Monday, December 17, 2007)]
[Notices]
[Page 71412]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-6057]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Expert Meeting on Disease Management Outcomes Measurement
AGENCY: Department of Health and Human Services, Office of the
Assistant Secretary for Planning and Evaluation.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the date and location of the Department
of Health and Human Services, Office of the Assistant Secretary for
Planning and Evaluation (HHS/ASPE) Expert Meeting on Disease Management
Outcomes Measurement. The objective of the meeting is to convene a
panel of experts from government, academia, and private industry to
discuss measurement of the impact of disease management on health
outcomes and costs of care, with a focus on potential for public sector
programs.
DATES: Wednesday, January 16, 2008, from 9 a.m. to 5 p.m. Eastern Time.
ADDRESSES: The Expert Meeting will be held at 1200 South Hayes Street,
Room 4204, Arlington, VA 22202-5050. Telephone: (703) 413-1100.
Registration procedures are described in the SUPPLEMENTARY INFORMATION
section below.
FOR FURTHER INFORMATION CONTACT: Adelle Simmons, Office of the
Assistant Secretary for Planning and Evaluation, 200 Independence
Avenue, SW., Washington, DC 20201. Telephone: (202) 690-5924.
SUPPLEMENTARY INFORMATION:
I. Background
In the face of increasing health care costs, evidence of the need
for system-wide health care quality improvement, and an aging
population, disease management seems an intuitively appealing way to
improve the coordination and quality of care, and ultimately improve
health outcomes. In broad terms, disease management refers to a system
of coordinated health care interventions and communications to help
patients address chronic health conditions. Commercial health plans and
large employers are embracing this strategy, and public purchasers of
health care services including the Centers for Medicare and Medicaid
Services (CMS) have implemented demonstration programs to evaluate
disease management for certain conditions.
Questions about the effectiveness of disease management remain, in
part, because the evaluation methods of vendors of large, population-
based programs often lack scientific validity. Conversely, vendors
often argue that scientifically credible approaches, like a randomized
controlled experiment that the Medicare Health Support pilot uses, are
not feasible for routine operation. Thus, the lack of universally
accepted yet feasible evaluation methods are a major obstacle to
adopting and improving disease management, because potential purchasers
of such programs find it hard to identify the best program design and
to monitor its success. A primary goal of this meeting is to consider
the variety of disease management programs and identify strategies to
improve the assessment of their impact on individuals with multiple
chronic conditions.
II. Registration
The meeting is open to the public, and pre-registration is
encouraged. Seating capacity is limited, so registration will be
accepted on a first-come, first-served basis. Registration can be
completed by sending an e-mail message to Ms. Emily Taylor of the RAND
Corporation at etaylor@rand.org (The RAND Corporation is the Contractor
to HHS/ASPE to provide logistical support for the Expert Meeting.) To
register by telephone, contact Ms. Taylor at (703) 413-1100 ext. 5793.
The following information must be provided when registering: Name,
Company/Organization, and address. A RAND Corporation staff member will
confirm registrations by mail, e-mail, or fax.
Note: In the event that the meeting must be canceled due to
inclement weather, the meeting will be held at a later date, and
registrants will be notified by RAND.
III. Special Accommodations
Individuals who are hearing- or visually-impaired and have special
requirements or a condition that requires special assistance must
request accommodation when registering for the meeting in order to
ensure that accommodations will be made.
Dated: December 12, 2007.
Mary M. McGeein,
Principal Deputy Assistant Secretary for Planning and Evaluation,
Department of Health and Human Services.
[FR Doc. 07-6057 Filed 12-14-07; 8:45 am]
BILLING CODE 4150-24-M